The applications of Bharat Biotech and Serum Institute of India are under consideration, while that of the Indian arm of Pfizer has not yet been taken up.
As Beijing offers its own Sinovac-made vaccine to Pakistan, Sri Lanka, Nepal and Bangladesh, India takes steps to have a locally-made vaccine distributed to friendly nations.
3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.
Margaret Keenan became the first person in the world to receive the Pfizer Covid vaccine outside trial conditions after it got the green light in the UK last week.
The recommendations on granting of authorisation will be made on three parameters — safety, quality and efficacy. The Drug Controller General of India will take the final decision.
After the nod from UK and Bahrain, the firm has sought permission to import the vaccine for sale and distribution besides waiver on clinical trials in India.
BioNTech’s shares have jumped almost 8% this week and are up more than 250% for the year. Sahin is now the 493rd-richest person on the planet with a net worth of $5.1 billion.
MoSPI proposes to remove closed factories from IIP sample, aiming for truer picture of India’s industrial health in upcoming 2022–23 base series. Plan open to public feedback until 25 November.
Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.
COMMENTS